Author:Sonictec · Updated
Similar licence names address different needs
Canadian medical device projects must distinguish MDL from MDEL. An MDL licenses a product; an MDEL licenses relevant establishment activities. Whether each is required and who applies depends on classification, manufacturer and import/distribution arrangements.
MDL: a specific medical device
Health Canada classifies medical devices by risk. Class II, III and IV devices generally need an MDL; Class I devices follow a different licensing arrangement. Confirm intended use and classification before assessing the evidence and quality system requirements.
MDEL: the activities of an establishment
MDEL requirements apply to relevant establishments engaged in activities such as manufacturing, importing and distributing. Verify each party's actual role and applicable exceptions. A product's MDL does not establish that every participant meets establishment requirements.
Commercial arrangements cannot replace regulatory assessment
Finding a local distributor is only part of market entry. Device licensing, establishment activities, labels, document coordination, supply and maintenance still require agreement. Canadian roles and licences cannot simply mirror Australia's Sponsor model.
Assess drugs and payment pathways separately
MDL and MDEL are medical device terms. Drug projects should be assessed under the applicable drug pathways. Market authorization, reimbursement, formulary listing and procurement should also be discussed separately.
Three types of information to prepare
Start with intended use and current classification, then overseas licences and quality systems, followed by Canadian target markets and partners. Sonictec's Canadian business is developing; this information supports discussion of registration preparation and channel scope.
Official references
Sources checked: 2026-09-15. Assess individual products and projects against current applicable requirements.